상세 보기
초록
Glucocorticoid (GC) is widely used as an anti-emetic drug, an anti-inflammatory drug, or a pain killer for cancer patients. Though only a few cases of GC-induced hepatopathy were reported, the clinical course were mild and reversible, and the GC has also been used for the treatment of autoimmune hepatitis. Here, we found a case of fatal hepatic failure in a 52-year-old man with relapsed diffuse large B-cell lymphoma following high-dose glucocorticoid. Computed tomography (CT) scan revealed shrinkage of liver volume and large amount of ascites, indicating the aggravation of liver cirrhosis. The laboratory finding was consistent with hepatic failure: high bilirubin and prolonged prothrombin time. The patient died of hepatic failure and sepsis. Here, we discussed the mechanism of glucocorticoid-induced hepatopathy and proposed a new hypothesis on the glucocorticoid-induced hepatic failure in the patient with underlying liver disease.
키워드
- 제목
- 악성 림프종 환자에서 고용량 스테로이드 요법에 의한 급성 간부전
- 제목 (타언어)
- Hepatic Failure Caused by High-dose Steroid in a Patient with Lymphoma
- 저자
- 김문진; 강명희; 김훈구; 강정훈; 이경원; 박경범; 이원섭; 정진명
- 발행일
- 2010
- 저널명
- 대한암예방학회지
- 권
- 15
- 호
- 4
- 페이지
- 257 ~ 261
- 언어
- KOR
- 출판사
- 대한암예방학회
- 발행국가
- 대한민국
- 분량
- 5 페이지
- ISSN
- E 2288-3657
P 2288-3649